
Lonza Group AG / Key word(s): Quarter Results Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland, 9 May 2025 - In its qualitative Q1 2025 update, Lonza reported a strong performance across its CDMO business in line with the Full-Year Outlook 2025. CHI progressed successfully on its recovery path in line with its Full-Year 2025 expectations. 1CDMO: Lonza excluding Capsules & Health Ingredients (CHI). About Lonza Our company generated sales of CHF 6.6 billion with a CORE EBITDA of CHF 1.9 billion in Full-Year 2024. Find out more at www.lonza.com. Lonza Contact Details Daniel Buchta Francesca Maguire End of Inside Information |
Language: | English |
Company: | Lonza Group AG |
Münchensteinerstrasse 38 | |
4052 Basel | |
Switzerland | |
Phone: | +4161 316 81 11 |
Internet: | www.lonza.com |
ISIN: | CH0013841017 |
Valor: | 1384101 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2133552 |
End of Announcement | EQS News Service |
2133552 09-May-2025 CET/CEST